Circulating calprotectin as a biomarker of COVID-19 severity

M Mahler, PL Meroni, M Infantino… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

[PDF][PDF] Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with …

V Quagliariello, A Paccone, M Iovine… - European Review for …, 2021 - europeanreview.org
Cytokines in cardiac tissue plays a key role in progression of cardiometabolic diseases and
cardiotoxicity induced by several anticancer drugs. Interleukin-1β is one on the most studied …

[PDF][PDF] COVID-19: an insight into SARS-CoV-2 pandemic originated at Wuhan City in Hubei Province of China

BS Mohan, V Nambiar - J Infect Dis Epidemiol, 2020 - pdfs.semanticscholar.org
Abstract Coronavirus disease 19 (COVID-19), originated at Wuhan city of China in early
December 2019 has rapidly widespread with confirmed cases in almost every country …

[HTML][HTML] A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome …

A Bektas, SH Schurman, C Franceschi, L Ferrucci - Immunity & Ageing, 2020 - Springer
A central clinical question as the world deals with the COVID-19 pandemic is what the long-
term sequelae for the millions of individuals will be who recover from the hyperinflammatory …

[HTML][HTML] Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

N Kaffash Farkhad, A Sedaghat, H Reihani… - Stem Cell Research & …, 2022 - Springer
Background Acute respiratory distress syndrome (ARDS) is the devastating complication of
the new COVID-19 pandemic, directly correlated with releasing large amounts of …

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

S Croci, MA Venneri, S Mantovani, C Fallerini… - Autophagy, 2022 - Taylor & Francis
The polymorphism L412F in TLR3 has been associated with several infectious diseases.
However, the mechanism underlying this association is still unexplored. Here, we show that …

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon

HC Hasselbalch, V Skov, L Kjær, C Ellervik… - Cytokine & growth factor …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits an interferon (IFN)
deficiency state, which aggravates the type I interferon deficiency and slow IFN responses …

Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19

A Saeedi-Boroujeni… - …, 2021 - Taylor & Francis
SARS-CoV-2 is a type of beta-CoV that develops acute pneumonia, which is an
inflammatory condition. A cytokine storm has been recognized as one of the leading causes …

[HTML][HTML] Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review

A Dey, K Vaishak, D Deka, AK Radhakrishnan, S Paul… - Infection, 2023 - Springer
Purpose The COVID-19 pandemic caused by the novel Severe Acute Respiratory Syndrome
Corona Virus 2 (SARS-CoV-2) has put the world in a medical crisis for the past three years; …

Etoposide: A rider on the cytokine storm

C Bailly - Cytokine, 2023 - Elsevier
For more than 40 years, the epipodophyllotoxin drug etoposide is prescribed to treat cancer.
This semi-synthetic compound remains extensively used to treat advanced small-cell lung …